# How to value a patent for an Indian startup: three methods with worked numbers

URL: https://zernyxhub.com/blog/patent-valuation-for-startups
Author: Sahil Sheikh, Regd. Patent & Trademark Agent, cRTTP
Published: 2026-10-27
Category: Licensing

> Patent valuation for startups in India, worked through: cost, market and relief-from-royalty methods on one example patent, with every calculation shown.

**Short answer:** Patent valuation for startups in India uses three methods. The cost approach adds up what it would cost to recreate the invention today. The market approach adjusts prices paid for similar patents. The income approach, usually relief from royalty, discounts the royalties the startup avoids paying. An Indian patent's legal life ends 20 years from its filing date.

A founder asks what the company's patent is worth. There is usually a reason: a co-founder is assigning the patent to the company for shares, a manufacturer wants a licence price, or an investor wants a number in the deck. Each needs a figure you can defend line by line.

Below, one invented patent is valued three ways, with every calculation shown; the sections, fees and methods are real. Treat it as a working guide: where the law asks for a registered valuer, you still need one.

## The short answer

Use three methods. The **cost approach** asks what it would cost to recreate the invention. The **market approach** adjusts prices paid for similar patents. The **income approach**, usually **relief from royalty**, values the royalty you avoid paying because you own the patent, discounted over its remaining useful life of at most 20 years from filing. With a credible sales forecast, lead with relief from royalty and use the other two as checks.

## When does a startup actually need a patent value?

Less often than founders think. In practice, early-stage investors price the company, then check that the company owns the patent, that the claims cover the product and that enough life is left. A standalone value is needed mainly in two cases. If a founder assigns a patent to the company for shares, [Section 62(1)(c) of the Companies Act, 2013](https://www.incometaxindia.gov.in/w/section-62-101) ties the issue price to a registered valuer's report. And if you sell or license the patent, you need your own walk-away number before the buyer names one.

The assignment itself must be in writing with all its terms (Section 68 of the Patents Act, 1970) and registered with the Controller under Section 69 on Form 16 (Rule 90 of the Patents Rules). Our guide to [patent assignment](https://zernyxhub.com/blog/patent-assignment-india) covers the steps. For when an MSME needs a professional valuation and what it costs, see [IP valuation for MSMEs](https://zernyxhub.com/blog/ip-valuation-for-msme).

## The example: a fictional startup and its patent

| Item | Assumption (all invented) |
|---|---|
| Company | "Startup A", a DPIIT-recognised maker of water-testing kits |
| Patent | Indian patent on a paper-strip sensor that detects arsenic in groundwater |
| Filed | 15 March 2023, complete specification, no provisional |
| Granted | 2026, after publication and then expedited examination on Form 18A |
| Official fees paid | Form 1 ₹1,600, Form 18A ₹8,000, renewals for years 3 and 4 at ₹800 each |
| Valuation date | 31 October 2026 |

The fees are the startup e-filing rates in IP India's [First Schedule of fees](https://www.ipindia.gov.in/storage/uploads/docs-operator/d7bed07b-5c56-404b-a0c8-152b4bd18f0f.pdf). Our guide on [startup patent fees](https://zernyxhub.com/academy#startup-sipp) explains how to qualify.

## How long will the patent earn anything?

[Section 53 of the Patents Act](https://ipindia.gov.in/writereaddata/Portal/ev/sections/ps53.html) sets the term at 20 years from the date of filing, and the patent ceases if a renewal fee is not paid in time. For a PCT application entering India, the 20 years run from the international filing date.

Startup A's patent expires on 15 March 2043: 16.4 years of legal life from the valuation date. The founders, though, expect newer sensors to overtake the strip in about eight years. [ICAI training material](https://old.wirc-icai.org/images/material/valuation-standards-241118.pdf) on VS 302, the Indian valuation standard for intangible assets, says useful life depends on legal, functional, economic and technological factors. In practice the cash flows stop at whichever ends first, so this valuation uses eight years.

**Startup A's patent: legal life against economic life**
- 15 Mar 2023, Application filed: The 20-year term starts here
- 2026, Patent granted
- 31 Oct 2026, Valuation date: 16.4 years of legal life left
- Oct 2034, Economic life ends: Newer sensors expected to take over
- 15 Mar 2043, Legal expiry: Section 53: 20 years from filing

## Method 1: what would it cost to recreate the invention?

**Reproduction cost** is what the original effort cost. **Replacement cost** strips out work a fresh team would not repeat, such as dead ends. Add a return for the developer's effort and risk, then deduct obsolescence. ICAI VS 103, as summarised in the same material, says the cost approach fits an asset that can be quickly recreated with substantially the same utility.

| Line | ₹ lakh |
|---|---|
| Researcher time: 2 people × 18 months × ₹1 lakh a month | 36.00 |
| Materials, prototypes and field testing | 14.00 |
| Lab access and equipment hire | 6.00 |
| Official patent fees (₹1,600 + ₹8,000 + 2 × ₹800) | 0.11 |
| Patent agent's drafting and prosecution fees | 2.50 |
| **Reproduction cost** | **58.61** |
| Less: dead-end work a fresh team would skip | (12.00) |
| **Replacement cost** | **46.61** |
| Add: developer's return at 15% | 6.99 |
| Less: obsolescence at 10% of ₹53.60 lakh | (5.36) |
| **Cost approach value** | **48.24** |

The limit: cost has no link to what the patent earns. A large research budget can end in a patent nobody wants. Use the cost figure as a sanity check, or as the main method only when no forecast stands up.

## Method 2: what have similar patents sold for?

The market approach adjusts prices paid for comparable patents. The idea is sound; the data is the problem. Most Indian patent sales and licences are confidential, and the few you find rarely match closely. ICAI VS 103 points to other approaches where the asset and the comparables differ materially, or where there is not enough information on the comparable deals.

Suppose Startup A finds three deals, all invented here.

| Comparable (invented) | Price (₹ lakh) | Adjustments | Adjusted (₹ lakh) |
|---|---|---|---|
| A: granted patent, fluoride test kit, already selling | 80 | × 0.80 for its later stage; × 1.10 as only 12 years were left | 70.40 |
| B: pending application, heavy-metal sensor | 45 | × 1.25 because ours is granted; × 0.90 for its broader claims | 50.63 |
| C: patent sold with know-how and two trained staff | 110 | × 0.65 to remove know-how and people; × 0.90 for its larger market | 64.35 |
| **Average** | | | **61.79** |

Every multiplier is a judgement a valuer would justify in writing. Treat this as the least reliable figure.

## Method 3: what royalty does owning the patent save?

Relief from royalty asks: if Startup A did not own this patent, what would it pay to license it? The ICAI material describes it as the present value of the royalty payments saved by owning the asset, over its remaining useful life.

**Relief from royalty, in five steps**
1. Forecast sales: Over the patent's useful life
2. Pick a royalty rate: What an independent licensee would pay
3. Deduct tax: At your effective tax rate
4. Discount each year: At a rate that reflects the risk
5. Add it up: The patent's value today

The assumptions, all illustrative: a royalty of **5% of net sales** from comparable licences (see [how much royalty is fair](https://zernyxhub.com/blog/royalty-rates) for how a rate is argued); tax at a round **25%**, so use your actual effective rate; and a discount rate of **30%** for a young company with one product. Each year's discount factor is 1 ÷ 1.30 raised to the year number, with cash at year end.

| Year | Sales (₹ crore) | Royalty saved at 5% (₹ lakh) | After 25% tax (₹ lakh) | Discount factor | Present value (₹ lakh) |
|---|---|---|---|---|---|
| 1 | 1.0 | 5.00 | 3.75 | 0.7692 | 2.88 |
| 2 | 2.5 | 12.50 | 9.38 | 0.5917 | 5.55 |
| 3 | 4.5 | 22.50 | 16.88 | 0.4552 | 7.68 |
| 4 | 6.5 | 32.50 | 24.38 | 0.3501 | 8.53 |
| 5 | 8.0 | 40.00 | 30.00 | 0.2693 | 8.08 |
| 6 | 8.5 | 42.50 | 31.88 | 0.2072 | 6.60 |
| 7 | 8.5 | 42.50 | 31.88 | 0.1594 | 5.08 |
| 8 | 8.0 | 40.00 | 30.00 | 0.1226 | 3.68 |
| **Total** | **47.5** | **237.50** | **178.13** | | **48.09** |

So ₹2.38 crore of royalties saved over eight years is worth about ₹48.1 lakh today. The royalty rate and the discount rate move the answer most:

| Royalty rate | Discount 25% | Discount 30% | Discount 35% |
|---|---|---|---|
| 4% | ₹46.0 lakh | ₹38.5 lakh | ₹32.6 lakh |
| 5% | ₹57.5 lakh | ₹48.1 lakh | ₹40.7 lakh |
| 6% | ₹69.0 lakh | ₹57.7 lakh | ₹48.8 lakh |

Life matters too: cut it from eight years to six and the value falls to ₹39.3 lakh. For a pending application, run the same table and multiply by a probability of grant you can defend.

## Putting the three numbers side by side

| Method | Value (₹ lakh) | Main weakness |
|---|---|---|
| Cost approach | 48.24 | Ignores what the patent earns |
| Market approach | 61.79 | Weak comparables |
| Relief from royalty | 48.09 | Depends on the forecast and discount rate |

Weighting relief from royalty at 60%, cost at 25% and market at 15% gives about ₹50.2 lakh, so a defensible range for Startup A's patent is roughly ₹45 to 55 lakh. Our view: for a startup with real sales or signed orders, lead with relief from royalty, because it ties the number to the patent's earning power, and report the other two to show you checked. Our guide on [how to put a price on a technology](https://zernyxhub.com/academy#value-tech) covers the deal side once you have the number.

## Which method do investors and registered valuers rely on?

Investors mostly value the company; the patent changes how much risk they see. They test your inputs: ownership, remaining life, claim scope and the forecast.

[IBBI's FAQ for valuers](https://ibbi.gov.in/uploads/faqs/FAQsforRegistrationasaValuer-Individual-01October2021.pdf) says that since 1 February 2019 only registered valuers can carry out valuations under the Companies Act and the Insolvency and Bankruptcy Code. IBBI registers them in three asset classes (Land and Building, Plant and Machinery, Securities or Financial Assets), and a valuer may value only their own class. IBBI's [2026 syllabus for Securities or Financial Assets](https://ibbi.gov.in/uploads/exams/2026Syllabus-SFA.pdf) covers intangibles, names the relief-from-royalty method and lists the International Valuation Standards as updated in January 2025. [ICAI's Valuation Standards 2018](https://www.icai.org/post/15070), including ICAI VS 302 on intangible assets, apply to reports issued on or after 1 July 2018 for engagements under the Companies Act, until the central government notifies its own standards.

In practice, valuers lean on an income method when the patent sits behind a product with a forecast, on cost when the invention is early, and on market data mostly as a cross-check, because Indian deal data is thin. Discount rates vary between valuers, which is one more reason to show your working.

## Mistakes founders make

- Using the full 20 years when the product will be obsolete in eight.
- Valuing a patent the company does not own, because the assignment was never signed, or cannot prove it owns, because the assignment was never registered: under Section 69(5) an unregistered assignment is not admitted as evidence of title unless the Controller or court directs otherwise.
- Forgetting renewals: under Section 53, an unpaid renewal fee ends the patent, and its value with it.

If you plan to license the patent to a manufacturer instead of selling kits yourself, the sales line in Method 3 becomes the licensee's sales, and the uses you list decide how large it can be. [Zernyx Hub](https://www.zernyxhub.com) has mapped patents from universities across India, and its AI gives business insight on each one, including its commercial applications, useful for testing the applications in your forecast.

## Common questions

### Do investors pay for a separate patent valuation in an Indian startup?

Usually not at seed or early stage. Investors price the company as a whole, then check that the company owns the patent, that the claims cover the product and that enough life is left. A separate patent value matters when shares are issued for the patent, or when the patent is sold or licensed.

### Who can value a patent when a startup issues shares in exchange for it?

A registered valuer. Section 62(1)(c) of the Companies Act, 2013 ties the price of such an issue to a registered valuer's report. IBBI's FAQ for valuers says that since 1 February 2019 only registered valuers can carry out valuations under the Companies Act and the Insolvency and Bankruptcy Code.

### How many years of a patent's life should a valuation use?

The shorter of the legal and the economic life. Under Section 53 of the Patents Act, an Indian patent lasts 20 years from the filing date, provided renewal fees are paid. If the product will be overtaken sooner, the cash flows stop when it is.

### Can a pending patent application be valued?

Yes, but the value is lower. Run the same methods, then multiply by a probability of grant you can defend from the examination report and the closest prior art, and say so in the report.

### Which royalty rate should go into the relief-from-royalty method?

The rate an independent licensee would pay for the same rights, taken from comparable licences and adjusted for readiness, exclusivity and patent strength. No law sets it, so show where your rate comes from.

---

Published by Zernyx Hub. More: https://zernyxhub.com/llms.txt
